Ceftriaxone susceptibility of oxacillin-susceptible Staphylococcus aureus from patients with prosthetic joint infection

Kerryl E. Greenwood-Quaintance, Peggy Kohner, Douglas R. Osmon, Abinash Virk, Robin Patel

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Ceftriaxone is used to treat oxacillin-susceptible S. aureus (OSSA) prosthetic joint infection (PJI). Susceptibility of ceftriaxone against OSSA has been questioned. Ceftriaxone susceptibility was determined against 100 PJI OSSA isolates. Ceftriaxone MIC<inf>90</inf>/MIC<inf>50</inf> were 8/4 and 4/3μg/mL by broth microdilution and Etest, respectively. Ceftriaxone susceptibility is inferable by oxacillin susceptibility.

Original languageEnglish (US)
Pages (from-to)177-178
Number of pages2
JournalDiagnostic Microbiology and Infectious Disease
Volume82
Issue number2
DOIs
StatePublished - Jun 1 2015

Fingerprint

Oxacillin
Ceftriaxone
Staphylococcus aureus
Joints
Infection
Disk Diffusion Antimicrobial Tests

Keywords

  • Ceftriaxone
  • Oxacillin-susceptible Staphylococcus aureus
  • Prosthetic joint infection

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Ceftriaxone susceptibility of oxacillin-susceptible Staphylococcus aureus from patients with prosthetic joint infection. / Greenwood-Quaintance, Kerryl E.; Kohner, Peggy; Osmon, Douglas R.; Virk, Abinash; Patel, Robin.

In: Diagnostic Microbiology and Infectious Disease, Vol. 82, No. 2, 01.06.2015, p. 177-178.

Research output: Contribution to journalArticle

Greenwood-Quaintance, Kerryl E. ; Kohner, Peggy ; Osmon, Douglas R. ; Virk, Abinash ; Patel, Robin. / Ceftriaxone susceptibility of oxacillin-susceptible Staphylococcus aureus from patients with prosthetic joint infection. In: Diagnostic Microbiology and Infectious Disease. 2015 ; Vol. 82, No. 2. pp. 177-178.
@article{de819265b0dc47ce9fde9ce2ab9345a2,
title = "Ceftriaxone susceptibility of oxacillin-susceptible Staphylococcus aureus from patients with prosthetic joint infection",
abstract = "Ceftriaxone is used to treat oxacillin-susceptible S. aureus (OSSA) prosthetic joint infection (PJI). Susceptibility of ceftriaxone against OSSA has been questioned. Ceftriaxone susceptibility was determined against 100 PJI OSSA isolates. Ceftriaxone MIC90/MIC50 were 8/4 and 4/3μg/mL by broth microdilution and Etest, respectively. Ceftriaxone susceptibility is inferable by oxacillin susceptibility.",
keywords = "Ceftriaxone, Oxacillin-susceptible Staphylococcus aureus, Prosthetic joint infection",
author = "Greenwood-Quaintance, {Kerryl E.} and Peggy Kohner and Osmon, {Douglas R.} and Abinash Virk and Robin Patel",
year = "2015",
month = "6",
day = "1",
doi = "10.1016/j.diagmicrobio.2015.03.002",
language = "English (US)",
volume = "82",
pages = "177--178",
journal = "Diagnostic Microbiology and Infectious Disease",
issn = "0732-8893",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Ceftriaxone susceptibility of oxacillin-susceptible Staphylococcus aureus from patients with prosthetic joint infection

AU - Greenwood-Quaintance, Kerryl E.

AU - Kohner, Peggy

AU - Osmon, Douglas R.

AU - Virk, Abinash

AU - Patel, Robin

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Ceftriaxone is used to treat oxacillin-susceptible S. aureus (OSSA) prosthetic joint infection (PJI). Susceptibility of ceftriaxone against OSSA has been questioned. Ceftriaxone susceptibility was determined against 100 PJI OSSA isolates. Ceftriaxone MIC90/MIC50 were 8/4 and 4/3μg/mL by broth microdilution and Etest, respectively. Ceftriaxone susceptibility is inferable by oxacillin susceptibility.

AB - Ceftriaxone is used to treat oxacillin-susceptible S. aureus (OSSA) prosthetic joint infection (PJI). Susceptibility of ceftriaxone against OSSA has been questioned. Ceftriaxone susceptibility was determined against 100 PJI OSSA isolates. Ceftriaxone MIC90/MIC50 were 8/4 and 4/3μg/mL by broth microdilution and Etest, respectively. Ceftriaxone susceptibility is inferable by oxacillin susceptibility.

KW - Ceftriaxone

KW - Oxacillin-susceptible Staphylococcus aureus

KW - Prosthetic joint infection

UR - http://www.scopus.com/inward/record.url?scp=84929045353&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929045353&partnerID=8YFLogxK

U2 - 10.1016/j.diagmicrobio.2015.03.002

DO - 10.1016/j.diagmicrobio.2015.03.002

M3 - Article

C2 - 25842182

AN - SCOPUS:84929045353

VL - 82

SP - 177

EP - 178

JO - Diagnostic Microbiology and Infectious Disease

JF - Diagnostic Microbiology and Infectious Disease

SN - 0732-8893

IS - 2

ER -